These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24597388)

  • 1. How are pharmaceutical patent term extensions justified? Australia's evolving scheme.
    Lawson C
    J Law Med; 2013 Dec; 21(2):379-98. PubMed ID: 24597388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legitimate patent extension or patent system abuse?
    Atkinson JD; Moodie RS
    Pharm Pat Anal; 2013 May; 2(3):317-24. PubMed ID: 24237059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Freedom of information applications as an "evergreening" tactic: Secretary, Department of Health and Ageing v iNOVA Pharmaceuticals (Australia) Pty Ltd (2010) 191 FCR 573; [2010] FCA 1442.
    Vines T; Faunce T
    J Law Med; 2011 Sep; 19(1):43-52. PubMed ID: 21988009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocratic obligation to shareholder profit? Medical treatment patents and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50.
    Vines T
    J Law Med; 2014 Jun; 21(4):797-809. PubMed ID: 25087362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilars: The Challenges of Novelty, Inventive Step and Sufficiency.
    Henriksen T; Sanderson J
    J Law Med; 2018 Jul; 25(4):973-991. PubMed ID: 29978679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent term extensions: issues, challenges and implications for pharmaceuticals.
    Clark L; Beadle D
    Pharm Pat Anal; 2012 Sep; 1(4):427-35. PubMed ID: 24236881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Sufficiency" for living organism inventions under the Patents Act 1990 (Cth).
    Lawson C
    J Law Med; 2004 Feb; 11(3):373-81. PubMed ID: 15018213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme.
    Harvey K
    Aust Health Rev; 2004 Nov; 28(2):218-26. PubMed ID: 15527402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced scope for extension of patent term for pharmaceuticals under Australian law.
    Lyons M; Stark A
    Pharm Pat Anal; 2015; 4(5):351-5. PubMed ID: 26490425
    [No Abstract]   [Full Text] [Related]  

  • 10. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent litigation in India continues to throw up new challenges.
    Reddy Thikkavarapu P
    Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AUSTRALIAN COMPETITION AND CONSUMER COMMISSION v PFIZER: EVERGREENING AND MARKET POWER AS A BLOCKBUSTER DRUG GOES OFF PATENT.
    Faunce T
    J Law Med; 2015 Jun; 22(4):771-87. PubMed ID: 26349378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceuticals, patents, and politics: Canada and Bill C-22.
    Lexchin J
    Int J Health Serv; 1993; 23(1):147-60. PubMed ID: 8425783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney.
    Melethil S
    AAPS J; 2005 Oct; 7(3):E723-8. PubMed ID: 16353948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patents and the obligation to protect health: examining the significance of human rights considerations in the protection of pharmaceutical patents.
    Owoeye OA
    J Law Med; 2014 Jun; 21(4):900-19. PubMed ID: 25087369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revitalizing the patent system to incentivize pharmaceutical innovation: the potential of claims with means-plus-function clauses.
    Tang WL
    Duke Law J; 2013 Feb; 62(5):1069-108. PubMed ID: 25330553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel rules against Canada on patent terms for pre-TRIPS patents.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical patent law: the Canadian perspective.
    Aumand L; Norman J
    Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
    Lewis RA
    J Contemp Health Law Policy; 1992; 8():361-78. PubMed ID: 10118987
    [No Abstract]   [Full Text] [Related]  

  • 20. How would patent reform legislation in the United States impact the pharmaceutical industry?
    Williams AW
    Expert Opin Ther Pat; 2015 Feb; 25(2):131-3. PubMed ID: 25387953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.